Terri Wilder, M.S.W.
Terri L. Wilder, M.S.W., has been part of the HIV community since 1989, and has been a reporter and writer for TheBody/TheBodyPro since 2007. She served on the New York Governor's Task Force to End AIDS, was recognized by POZ magazine for her work in HIV, and is highlighted in the book Fag Hags, Divas and Moms: The Legacy of Straight Women in the AIDS Community by Victoria Noe. She loves this community and will keep fighting until the epidemic is over.
Latest by Terri Wilder, M.S.W.
For PrEP to Work, Shared Doctor-Patient Decision-Making Is Key
The process of choosing between PrEP options is often not straightforward. Oni Blackstock, M.D., explains how providers can help ensure their patients end up with the most successful option for them.
HIV Clinicians Have Played a Key Role in U.S. COVID-19 Treatment Guidelines. We Spoke With One of Them.
COVID-19 Treatment Guidelines Panel member Arthur Kim, M.D., discusses the guidelines and the experience of treating COVID-19 from an HIV care provider’s perspective.
Understanding U=U Can Improve Health Outcomes for People Living with HIV—but the Message Matters
W. David Hardy, M.D., discusses the takeaway messages for HIV care providers after a recent research paper found that a third of all people living with HIV reported never discussing U=U with their provider.
Smoking Rates Are Higher in the LGBTQ Community; Can More Inclusive Data Help?
Scout, Ph.D., the head of the National LGBT Cancer Network, lays out the current state of the interplay between nicotine, cancer, HIV, and people who are LGBTQ.
Are Monoclonal Antibodies the Future of COVID-19 Treatment?
Infectious-diseases researcher David Wohl, M.D., talks about a major COVID-19 treatment trial in the works—and how it relates to our efforts against HIV.
Immediate HIV Treatment Initiation With Integrase Inhibitors Leads to Large Drop in Secondary HIV Transmission Among MSM
Integrase inhibitors are known to be potent first-line therapy options. Recent research suggests their benefits extend to onward HIV prevention as well.
Remembering Peter Stinner, a Keystone of Atlanta’s HIV Community
Stinner's husband, Jeff Graham, and colleague, Jonathan Colasanti, M.D., share a trove of stories about a person who embodied the ideals of empathy and care in HIV and health services.
With Several Curative Therapies for Hepatitis C on the Market, the Research Pipeline for Prevention Continues
The authors of an influential annual report on hepatitis C research and development talk through what's new and evolving in clinical science.
A Vaginal Ring to Prevent HIV Was Given a Positive Opinion by a European Drug Regulator. Here’s What You Need to Know About It.
Two experts discuss the history of the ring, how it works, and when it may come to the United States.
To Increase Access to HIV Post-Exposure Prophylaxis, New York State Updated Its Guidelines for Clinicians
If you’re a provider in or outside the state, you’ll want to read these new guidelines.